Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coca-Cola
- Development stage
- Unknown
- Lead developer
- The Coca-Cola Company
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Coca-Cola is a popular carbonated soft drink invented in 1886 by pharmacist John Stith Pemberton. Originally marketed as a patent medicine, its early formulation contained extracts from coca leaves (which provided cocaine) and kola nuts (a source of caffeine). While cocaine was removed from the formula around 1903, the drink continues to contain caffeine and natural flavors derived from coca leaves (after cocaine extraction). It is primarily consumed as a beverage, though it has been anecdotally used for ailments like nausea and gastric phytobezoars.
- Brand names
- Coca-ColaCoke
Beyond the preview
Go deeper on Coca-Cola.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Coca-Cola.